Teva Takeda Yakuhin

Teva Takeda Yakuhin is a Japanese pharmaceutical company established as a joint venture between Teva Pharmaceutical Industries and Takeda Pharmaceutical Company. The company was formed to combine Takeda's extensive distribution network and brand reputation in Japan with Teva's global expertise in generic drug manufacturing and supply chain management. It primarily focuses on the commercialization and distribution of "Long Listed Products"—off-patent brand-name drugs originally developed by Takeda—as well as a broad portfolio of generic medicines. The business model is designed to meet the Japanese government's objective of increasing generic drug penetration to reduce healthcare costs. Following a strategic divestment of certain generic assets in 2021, the company continues to operate as a key player in the Japanese off-patent medication market.